H1
Summary active Updated May 31, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
H1 is a New York-based AI-powered healthcare-information platform that helps pharmaceutical, health-plan, health-system, and technology customers identify and engage the right physicians across critical clinical and commercial workflows, co-founded and led by CEO Ariel Katz 123. H1 reports 85% of the top 20 pharma companies and 9 of the top 10 health plans as customers; recent CVS Health collaborations include a new AI model that substantially improved healthcare-provider directory accuracy 12. The $40M round announced May 28, 2026 was led by CVS Health Ventures (Partner Justin Brock); other participants were not disclosed and the round follows multiple operational collaborations between H1 and CVS Health 123.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-05-28 | Growth | $40M | CVS Health Ventures | — 123 |
What Investors Say
No independently sourced investor quotes found at this time.
What Founders Say
“This collaboration with CVS Health Ventures further enables H1 to achieve its mission of connecting the world to the right doctor.”
— Ariel Katz, Co-Founder & CEO, H1 1
Sources
-
GlobeNewsWire, “H1 Receives $40M Investment in Round Led by CVS Health Ventures,” May 28, 2026. Accessed May 2026. https://www.globenewswire.com/news-release/2026/05/28/3303059/0/en/h1-receives-40m-investment-in-round-led-by-cvs-health-ventures.html↩↩↩↩↩
-
Yahoo Finance (GlobeNewsWire), “H1 Receives $40M Investment in Round Led by CVS Health Ventures,” May 28, 2026. Accessed May 2026. https://finance.yahoo.com/sectors/healthcare/articles/h1-receives-40m-investment-round-150000008.html↩↩↩↩
-
Dealroom, “H1 raises $40M from CVS Health Ventures,” May 2026. Accessed May 2026. https://app.dealroom.co/news/note/h1-raises-40m-from-cvs-health-ventures↩↩↩